Advisory Board October 21, 2024

Recently, retail pharmacies like CVS and Walgreens have faced significant financial difficulties, leading them to lay off workers, reduce services, and halt previously announced expansion plans.

5 PBM strategies to watch

CVS discontinues infusion services as part of cost-cutting measures

Over the last few years, CVS has struggled with declining profit margins at its retail pharmacies, as well as rising costs of patient care through its insurance unit Aetna, which generates around a third of the company’s revenue. So far, CVS has cut its 2024 earnings forecast for three straight quarters.

Currently, the company is conducting a strategic review of options, including a potential breakup of its businesses, people familiar with the matter said. CVS has also met with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
340B purchases hit $66.3B in 2023
Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer
Will Pharma Increase Use of Personalized Audio Use in Marketing?
Pharma Pulse 10/21/24: Challenges of Proper GLP-1 Disposal, People Do Not Stick With GLP-1s for Weight Loss & more
STAT+: Catalent tries to reassure customers about its deal with Novo Holdings

Share This Article